Sign inJoin waitlistJoin the waitlist

John Hyngstrom

Research Director, Skin Cancer Program · Rush University Medical Center

Credentials: · · · · ·

History

Skin Cancer Program · Rush University Medical Center
Present
Rush University Medical Center
Present

National Cancer Institute
2010–2011
Complex General Surgical Oncology
University of Texas M D Anderson Cancer Center
2008–2010
General Surgery
University of Chicago Medical Center
2003–2008
University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine
1999–2003
Washington University
1995–1999

Research

Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
New England Journal of Medicine · 2023 · 739 citations
Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base
Annals of Surgical Oncology · 2012 · First of 9 authors · 289 citations
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma
Journal of Clinical Oncology · 2023 · 257 citations

Tawnya Bowles
20 papers
RA
Robert Andtbacka
17 papers
KG
Kenneth Grossmann
12 papers
Douglas Grossman
9 papers
Mark Faries
9 papers
Siwen Hu-Lieskovan
9 papers · 2 as a fellow
David Wada
8 papers · 1 as a fellow
AB
Adam Berger
7 papers
Elliot Asare
7 papers
GB
Glen Bowen
7 papers
Montaser Shaheen
7 papers
AH
Annelies Hickerson
5 papers · 4 as a resident

Clinical trials

Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)
Principal investigator · Active not recruiting
University of Utah
2020–2025